[Programmed Necrosis Inducers for Cancer Treatment].

Abstract

Programmed necrosis,a mode of cell death independent of Caspase,is mainly mediated by receptor-interacting protein kinase-1 (RIPK1),receptor-interacting protein kinase-3 (RIPK3),and mixed lineage kinase domain-like protein (MLKL).Studies have demonstrated that programmed necrosis has the dual role of promoting and inhibiting tumor growth and thus we can control the development of tumor by regulating programmed necrosis.The drugs capable of inducing programmed necrosis show potential anti-tumor activity.In addition,inducing programmed necrosis is an effective way to overcome tumor resistance to apoptosis.This paper summarized the mechanisms of programmed necrosis and its relationship with tumors.We focused on the antitumor activity of programmed necrosis inducers including natural products,chemotherapeutic drugs,death receptor ligands,kinase inhibitors,inorganic salts,metal complexes,and metal nanoparticles.These agents will provide new therapeutic candidates for the treatment of tumors,especially the tumors acquiring resistance to apoptosis.

• Authors: Qi Zhao, Li-Jun Yang, Yan-Bo Zheng, Jian-Hua Gong
• Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae (Zhongguo Yi Xue Ke Xue Yuan Xue Bao) Vol. 44 Issue 2 Pg. 338-347 (Apr 2022) ISSN: 1000-503X [Print] China
• PMID: 35538772 (Publication Type: Journal Article)

Chemical References

• Protein Kinases

Topics

• Apoptosis
• Cell Death
• Humans
• Necrosis (metabolism, pathology)
• Neoplasms (drug therapy)
• Protein Kinases (metabolism, pharmacology)